Hedgehog transduces signal by promoting cell surface expression of the seven-transmembrane protein Smoothened (Smo) in Drosophila, but the underlying mechanism remains unknown. Here we demonstrate that Smo is downregulated by ubiquitin-mediated endocytosis and degradation, and that Hh increases Smo cell surface expression by inhibiting its ubiquitination. We find that Smo is ubiquitinated at multiple Lysine residues including those in its autoinhibitory domain (SAID), leading to endocytosis and degradation of Smo by both lysosome-and proteasome-dependent mechanisms. Hh inhibits Smo ubiquitination via PKA/CK1-mediated phosphorylation of SAID, leading to Smo cell surface accumulation. Inactivation of the ubiquitin activating enzyme Uba1 or perturbation of multiple components of the endocytic machinery leads to Smo accumulation and Hh pathway activation. In addition, we find that the non-visual b-arrestin Kurtz (Krz) interacts with Smo and acts in parallel with ubiquitination to downregulate Smo. Finally, we show that Smo ubiquitination is counteracted by the deubiquitinating enzyme UBPY/USP8. Gain and loss of UBPY lead to reciprocal changes in Smo cell surface expression. Taken together, our results suggest that ubiquitination plays a key role in the downregulation of Smo to keep Hh pathway activity off in the absence of the ligand, and that Hh-induced phosphorylation promotes Smo cell surface accumulation by inhibiting its ubiquitination, which contributes to Hh pathway activation.
Introduction
Hedgehog (Hh) signaling governs cell growth and patterning in species ranging from insects to human [1, 2] . Because of its pivotal role in embryonic development and adult tissue homeostasis, misregulation of Hh signaling activity has been linked to many human disorders including birth defects and cancers [1, 3, 4] . Hh exerts its biological influence through a largely conserved signaling cascade that culminates at the activation of latent transcription factors Cubitus interruptus (Ci)/Gli [1] .
The core Hh reception system consists of a 12-transmembrane protein Patched (Ptc) that acts as the Hh receptor and a seventransmembrane protein Smo that acts as the Hh signal transducer [5, 6] . Hh and Ptc reciprocally regulate the subcellular localization and active state of Smo [7] [8] [9] [10] . In Drosophila, Hh stimulation or loss of Ptc leads to cell surface accumulation of Smo [7, 11] . Increased cell surface expression and activation of Smo are regulated by Hh-induced and PKA/CK1-mediated phosphorylation of Smo carboxyl intracellular tail (C-tail) [12] [13] [14] .
Several observations suggest that Smo cell surface expression is controlled by endocytic trafficking. A transmission electron microscopic study of Drosophila imaginal discs indicated that Smo is localized primarily in the lysosome of anterior compartment cells but is enriched on the plasma membrane of posterior compartment cells [15] . In Drosophila salivary gland cells, blocking endocytosis promotes Smo cell surface accumulation [11] . Using antibody uptake assay in S2 cells, we have shown that Smo reaches the cell surface but quickly internalizes in the absence of Hh and that Hh stimulation diminishes internalized Smo with a concomitant increase in cell surface Smo [13] . Taken together, these observations suggest that Hh signaling may regulate Smo cell surface expression by blocking its endocytosis and/or promoting its recycling back to the cell surface after internalization.
The mechanisms by which Smo endocytic trafficking and cell surface expression are regulated have remained unknown. Smo intracellular regions lack recognizable endosomal-lysosomal sorting signals such as the NPXY and dileucine-based motifs [16] . However, many membrane receptors are internalized after covalently modified by ubiquitination, as has been demonstrated for receptor tyrosine kinases (RTKs) and G protein coupled receptors (GPCRs) [17, 18] . The close relationship between Smo and GPCRs prompted us to investigate whether Smo cell surface expression is regulated by the ubiquitin pathway. Here we provide both genetic and biochemical evidence that Smo trafficking and degradation are regulated through multi-site ubiquitination of Smo C-tail and that Hh promotes Smo cell surface expression by inhibiting its ubiquitination. We also provide evidence that the non-visual b-arrestin Kurtz (Krz) acts in parallel with Smo ubiquitination to control Smo cell surface expression, and that the deubiquitinating enzyme UBPY promotes Smo cell surface expression by counteracting Smo ubiquitination.
Results

Inactivation of the Ubiquitin-Activating Enzyme Uba1 Leads to Smo Accumulation
In Drosophila wing discs, Smo cell surface level is low in anterior (A) compartment cells away from the A/P boundary but is elevated in response to Hh in A-compartment cells near the A/P boundary or in posterior (P) compartment cells ( Figure 1A ) [7] . To determine whether Smo is downregulated by the ubiquitin pathway, we generated mutant clones for Uba1, which encodes the only ubiquitin-activating enzyme (E1) in Drosophila [19, 20] . We employed a temperature-sensitive allele of Uba1, Uba1 H33 , which behaves like a null allele at the restrictive temperature [19] . Uba1 H33 clones were induced at second instar larval stage (48-72 h AEL) by FRT/FLP mediated mitotic recombination. Larva carrying Uba1 H33 clones were grown at permissive temperature (18uC) for 3 d and then shifted to non-permissive temperature (30uC) for 24 h before dissection for immunostaining. We found that anteriorly situated Uba1 H33 clones accumulated high levels of Smo compared with neighboring wild type cells ( Figure 1A -B'), suggesting that Smo is downregulated via the ubiquitin pathway in the absence of Hh. Immunostaining with anti-Smo antibody before membrane permeabilization suggested that Smo was accumulated on the cell surface in anteriorly situated Uba1 H33 clones ( Figure S1A-A') . A 12-h temperature shift resulted in a less robust Smo accumulation in Uba1 H33 clones ( Figure S1B -B'), likely due to the perdurance of Uba1 activity. In general, Smo elevation coincided well with Uba1 mutant clones. Intriguingly, Uba1
H33 mutant cells situated in the posterior compartment also exhibited slightly higher levels of Smo than neighboring wild type cells (arrowhead in Figure 1B ), suggesting that a fraction of Smo still undergoes ubiquitin-mediated degradation in the presence of Hh.
Uba1 Regulates Smo Ubiquitination and Cell Surface Expression
To examine whether Smo is directly ubiquitinated and whether Uba1 is responsible for this activity, we carried out a cell-based ubiquitination assay (see Materials and Methods) [21] . We employed RNAi and/or pharmacological inhibitor to inactivate Uba1. S2 cells stably expressing a Myc-tagged Smo (Myc-Smo) were treated with Uba1 or control doublestranded RNA (dsRNA) in the absence or presence of PYR-41, a cell permeable E1 inhibitor [22] . The efficiency of Uba1 RNAi was confirmed by Western blot analysis of an exogenously expressed tagged Uba1 ( Figure 1C ). Myc-Smo was ubiquitinated efficiently in the absence of Uba1 inhibition ( Figure 1D) ; however, ubiquitination of Smo was attenuated by Uba1 RNAi and more significantly inhibited by PYR-41 ( Figure 1D ). The incomplete blockage of Smo ubiquitination by Uba1 RNAi is likely due to partial inactivation of Uba1 by the RNAi approach. Indeed, a combined treatment with Uba1 RNAi and PYR-41 resulted in a more complete inhibition of Smo ubiquitination ( Figure 1D) .
We next applied a cell-based immunostaining assay to determine whether Uba1 regulates Smo cell surface expression [13] . Myc-Smo expressing cells were treated with control or Uba1 dsRNA in the absence or presence of PYR-41. Cell surface and total Smo were visualized by immunostaining with an anti-SmoN antibody prior to and after cell membrane permeabilization, respectively. As shown in Figure 1E , inhibition of Uba1 either by RNAi or PYR-41 increased the levels of Smo cell surface expression and combined treatment resulted in more dramatic cell surface accumulation of Smo.
Perturbation of Endocytic Machinery Leads to Smo Accumulation and Hh Pathway Activation
Ubiquitinated membrane proteins are internalized through the endocytic pathway and targeted to lysosome for degradation [17] . We therefore examined the effect of inactivation of endocytic components on Smo accumulation in wing imaginal discs. We found that Smo was accumulated in intracellular puncta in mutant clones lacking the Drosophila homolog of HGF-regulated tyrosine kinase substrate (Hrs) (Figure 2A-A' ), a protein involved in sorting ubiquitinated membrane proteins into multivesicular bodies (MVBs) [23] . Of note, not all hrs mutant cells exhibited Smo puncta. This could be due to perdurance of Hrs activity and/or disc folding so that Smo puncta are present at different focal planes. RNAi of other endocytic components, including Tsg101 [24] , Avalanche (Avl), a Drosophila syntaxin located in early endosomes [25] , and Rab5, resulted in Smo accumulation in anterior compartment cells distant from the A/P boundary (arrows in Figure 2B -E), as well as Hh pathway activation as indicated by Ci accumulation and ectopic expression of a Hh target gene decapentaplegic (dpp) (Figure 2B -E). Taken together, these observations suggest that Smo is downregulated via the endocytic pathway in the absence of Hh.
Author Summary
The Hedgehog (Hh) family of secreted proteins governs cell growth and patterning in diverse species ranging from Drosophila to human. Hh signals across the cell surface membrane by regulating the subcellular location and conformation of a membrane protein called Smoothened (Smo). In Drosophila, Smo accumulates on the cell surface in response to Hh, whereas in the absence of Hh it is internalized and degraded. The molecular mechanisms that control this intracellular trafficking and degradation of Smo were unknown, but here we show that Smo is modified by attachment of several molecules of a small protein called ubiquitin, which tags it for internalization and degradation within the cell. Hh inhibits this ubiquitination of Smo by inducing another modification, phosphorylation, of its intracellular tail by two types of protein kinase enzymes. This loss of ubiquitination and gain of phosphorylation causes the accumulation of Smo at the cell surface. What's more, we find that another protein called Kurtz interacts with Smo and acts in parallel with the ubiquitination process to promote internalization of Smo, and that the deubiquitinating enzyme UBPY/USP8 counteracts ubiquitination of Smo to promote its cell surface accumulation. Our study demonstrates that reversible ubiquitination plays a key role in regulating Smo trafficking to and from the cell surface and thus it provides novel insights into the mechanism of Hh signaling from the outside to the inside of the cell.
Smo Is Degraded by Both Lysosome and Proteasome
Consistent with Smo being downregulated through the endocytic pathway, treating Myc-Smo expressing S2 cells with a lysosome inhibitor, NH 4 Cl, stabilized Smo ( Figure 3A) . Interestingly, treating cells with a proteasome inhibitor, MG132, stabilized Smo more dramatically than treating cells with NH 4 Cl ( Figure 3A) . Furthermore, combined treatment of cells with MG132 and NH 4 Cl had an additive effect on Smo stabilization ( Figure 3A) , suggesting that Smo is downregulated by both lysosome-and proteasome-dependent mechanisms. However, unlike the case of Hh stimulation or Uba1 inaction where Smo was accumulated on the cell surface, proteasome inhibition stabilized Smo in intracellular vesicles ( Figure 3B ). Double labeling with endosomal markers YFP-Rab5 (for early endosomes) or YFP-Rab7 (for late endosomes) revealed that Smo was stabilized in Rab7 positive late endosomes after MG132 treatment ( Figure 3C ). Taken together, these observations suggest that a fraction of internalized Smo was degraded by proteasome in the endocytic pathway before reaching to lysosome.
Hh Inhibits Smo Ubiquitination Via PKA/CK1-Mediated Phosphorylation
Hh induces Smo cell surface accumulation both in vitro and in vivo [7, 11, 13] . If Smo ubiquitination is responsible for its internalization, Hh may increase Smo cell surface expression by inhibiting its ubiquitination. Indeed, treating Myc-Smo stably expressing cells with Hh-conditioned medium markedly reduced but did not completely abolish Smo ubiquitination ( Figure 4A ). Similarly, Ptc RNAi also reduced Smo ubiquitination ( Figure 4B ).
Our previous study demonstrated that Hh induced Smo cell surface accumulation through PKA/CK1-mediated phosphorylation of Smo C-tail [13] . We therefore determined whether Hh regulates Smo ubiquitination in a manner depending on Smo phosphorylation. We found that Hh stimulation failed to inhibit Smo ubiquitination in the presence of a PKA inhibitor H-89 ( Figure 4C ). On the other hand, expressing a constitutively active PKA catalytic domain (mC*) inhibited Smo ubiquitination in the absence of Hh ( Figure 4D ). To further determine whether Smo ubiquitination is regulated by PKA/CK1-mediated phosphorylation of its C-tail, S2 cells were transfected with Myc-tagged wild type Smo, a phosphorylation deficient form of Smo (Smo SA ) with three PKA sites (S667, S687, and S740) mutated to Ala, or a phospho-mimetic form of Smo (Smo SD ) with three PKA/CK1 clusters mutated to Asp [13] , treated without or with Hh conditioned medium, and followed by the ubiquitination assay described above. As shown in Figure 4E ). In addition, we found that adding the phosphorylation-deficient form but not the phospho-mimetic form of SAID to Fz2 promotes the ubiquitination of the corresponding chimeric protein ( Figure 5E ). Taken together, these observations suggest that the SAID domain suffices to promote ubiquitination and internalization of a membrane protein in a manner inhibited by phosphorylation. Combined with our earlier work [8] , it seems that the SAID domain autonomously regulates ubiquitination independent of the C-terminal negatively charged region.
Smo Is Ubiquitinated at Multiple Lysine Residues
If Smo ubiquitination is responsible for its internalization and degradation, one would expect that ubiquitination-deficient Smo variants should be stabilized and accumulated on the cell surface. We therefore attempted to identify Lys residues responsible for Smo ubiquitination. In general, ubiquitin acceptor sites lack a strict consensus and target proteins can be ubiquitinated at multiple Lys residues. Smo C-tail and intracellular loops contain a total of 49 Lys residues, many of which may serve as ubiquitin acceptor sites, making it difficult to generate Smo variants devoid of ubiquitination. As deleting the SAID domain diminished Smo ubiquitination ( Figure 4G ), we speculated that this region might contain Lys residues critical for Smo ubiquitination. There are a total of 13 Lys residues between aa 661 and aa 818. We therefore constructed Smo K6R with K665, K695, K700, K702, K710, and K733 mutated to Arg; Smo K7R with K752, K753, K762, K772, K773, K782, and K801 mutated to Arg; and Smo K13R with all the 13 Lys residues mutated to Arg. Using the cell-based ubiquitination assay described above, we found that both Myc-Smo K6R and Myc-Smo K7R exhibited reduced ubiquitination compared with Myc-Smo ( Figure 6A ). The combined mutations (K13R) resulted in a more dramatic reduction in Smo ubiquitination ( Figure 6A ), suggesting that Smo is ubiquitinated at multiple Lys residues between aa 661 and aa 818. In addition, the residual ubiquitination of Myc-Smo K13R suggests that Smo is also ubiquitinated at one or more Lys residues outside the SAID domain.
Smo K13R Exhibits Increased Stability and Cell Surface Expression
We next determined whether the K13R mutation affects Smo stability and cell surface expression. 4 Cl but insensitive to MG132 treatment ( Figure 6C ), suggesting that inhibition of Smo ubiquitination blocks its degradation by proteasome.
To determine whether inhibition of Smo ubiquitination leads to its cell surface accumulation, S2 cells were transfected with MycSmo or Myc-Smo K13R expression construct, followed by treatment with or without Hh-conditioned medium. Cell surface and total Smo were monitored by immunostaining with the anti-SmoN antibody before and after cell permeabilization, respectively. As shown in Figure 6D , Myc-Smo K13R exhibited higher basal level of cell surface expression than Myc-Smo; however, the level of cell surface Myc-Smo K13R in the absence of Hh was still lower than that of Myc-Smo or Myc-Smo K13R in the presence of Hh ( Figure 6D ). Thus, although Smo K13R exhibits increased stability and cell surface expression, it is still internalized and degraded by lysosome and can be further stabilized by Hh.
To determine whether the K13R mutation affects Smo stability in vivo, we generated transgenic flies expressing either UAS-MycSmo or UAS-Myc-Smo K13R from the same genetic locus using the phiC31 integration system to ensure similar expression level from different constructs [26] . We used the wing specific Gal4 driver MS1096 coupled with tub-Gal80 ts to drive a pulse of UAS-Myc-Smo or UAS-Myc-Smo K13R expression by shifting late third instar larvae to the non-permissive temperature for 12 h. After chasing for 
Krz Promotes Smo Internalization by Binding to Its C-Tail
Internalization of Smo K13R is likely due to its residual ubiquitination at a Lys residue(s) outside the SAID domain. In addition, Smo K13R could also be internalized by Smo interacting proteins, as have been shown for other receptors [27, 28] . It has been shown that the non-visual arrestin, b-arrestin 2, can bind and internalize mammalian Smo [29] . The Drosophila non-visual arrestin is encoded by krz [30] . We therefore carried out both gain-and lossof-function studies to determine whether Krz regulates Smo cell surface expression. We found that overexpression of Krz in wing imaginal discs using a dorsal compartment specific Gal4 driver, apGal4, blocked Smo accumulation in posterior-dorsal compartment cells (compare Figure 7B with Figure 7A ). However, we found that Smo was not accumulated in krz mutant clones located in the anterior compartment of wing discs ( Figure 7C ). Similar observations were obtained by a recent study [31] . Figure S4 ). The effect of UBPY RNAi on Smo ubiquitination was confirmed by an independent dsRNA for UBPY ( Figure 8A ). We also found that inactivation of UBPY by RNAi increased Smo ubiquitination in the presence of Hh ( Figure 8A ), suggesting that UBPY counteracts Smo ubiquitination in both Hh signaling ''off'' and ''on'' states. Consistent with UBPY being able to counteract Smo ubiquitination independent of Hh signaling states, overexpression of UBPY reduced Smo ubiquitination in S2 cells both in the absence and presence of Hh ( Figure 8B ).
Smo Ubiquitination Is Counteracted by the
We then carried out coimmunoprecipitation assays to determine whether UBPY physically interacts with Smo. As shown in Figure 8C We next examined the effect of loss-or gain-of-UBPY on Smo cell surface expression. In wing discs carrying UBPY mutant clones, Smo cell surface accumulation was attenuated in Pcompartment situated UBPY mutant cells ( Figure 8E-E'' ). On the contrary, expression of UAS-UBPY using the wing specific Gal4 driver MS1096 resulted in Smo accumulation in anterior compartment cells away from the A/P boundary ( Figure 8G,J) . Similarly, overexpression of UBPY in S2 cells markedly increased the cell surface expression of Myc-Smo ( Figure 8K ). Overexpression of UBPY in wing discs stabilized full-length Ci (Figure 8G ',J') and induced ectopic expression of dpp-lacZ in anterior dorsal compartment cells where MS1096 was expressed at high levels ( Figure 8G'' ). Smo RNAi suppressed the ectopic dpp-lacZ expression induced by UBPY overexpression as well as the endogenous dpp-lacZ expression near the A/P boundary ( Figure 8H-H'' ). However, overexpression of UBPY induced little if any ectopic expression of ptc-lacZ ( Figure 8J'') , which is normally induced by higher levels of Hh signaling than dpp-lacZ. Taken together, these results suggest that UBPY can reverse Smo ubiquitination to promote its cell surface accumulation and induce low but not high levels of Hh pathway activation. This is in line with our previous finding that overexpression of wild type Smo only induced low levels of Hh pathway activation and full activation of Smo requires additional steps, including a phosphorylation-mediated conformational switch in Smo C-tail [7-10,13]. 
Smo Is Regulated by Both Mono-and Polyubiquitination
It is generally thought that monoubiquitination or multiubiquitination (monoubiquitination at multiple sites) is responsible for receptor internalization and degradation by lysosome, whereas Lys 48-linked polyubiquitination targets proteins for proteasomemediated degradation. The observation that Smo is degraded by both lysosome and proteasome dependent mechanisms implied that Smo might undergo both types of modification. To determine if Smo could be monoubiquitinated, Myc-Smo or its KR variants was coexpressed with a HA-tagged mutant form of Ub with all Lys residues mutated to Arg (HA-Ub K0 ) in S2 cells. In this case, addition of HA-Ub K0 prevents the formation of polyubiquitination chains, generating modified proteins with one or more sites monoubiquitinated. We found that Myc-Smo was effectively modified by HA-Ub K0 ( Figure 9A ). Figure 9A ), suggesting that Smo can be monoubiquitinated at multiple sites.
In the absence of proteasome inhibitor, HA-Ub K0 and wild type HA-Ub were incorporated into Myc-Smo at similar levels ( Figure 9B ), suggesting that the ubiquitinated Smo species modified by HA-Ub K0 or HA-Ub detected under these conditions were mostly mono-or multi-ubiquitinated. Furthermore, Hh stimulation inhibited Smo ubiquitination under these conditions ( Figure 9B ). However, after MG132 treatment, more HA-Ub conjugated Smo was detected than HA-Ub K0 modified Smo ( Figure 9B ), suggesting that a fraction of Myc-Smo underwent polyubiquitination that was normally degraded by proteasome. The proteasome inhibitor also increased the level of HA-Ub K0 conjugated Smo (Figure 9B ), suggesting that a fraction of HA- Figure 9C , immunoprecipitated Myc-Smo was recognized by the K48 antibody and the signal was markedly increased by MG132 treatment, suggesting that Smo can also be modified by Lys 48-linked polyubiquitination that targets it for proteasome-mediated degradation.
Discussion
Regulation of Smo cell surface expression is a key step in Hh signal transduction [7, 11, 13] , but the underlying mechanism has Early studies with yeast membrane receptors provided evidence that monoubiquitination of GPCRs mediates their agonistinduced internalization [33, 34] . Later studies with mammalian GPCRs and other receptors suggested that both mono-and polyubiquitination could be involved in receptor endocytosis and degradation [18] . However, it has been shown that ''polyubiquitination'' of some receptors is due to monoubiquitination at multiple sites (multiubiquitination) instead of forming a polyubiquitination chain at a single site [35, 36] . Here we provide evidence that Smo is both mono-and polyubiquitinated. It is possible that mono-or multiubiquitination may lead to Smo internalization and that internalized Smo could be further ubiquitinated in the endocytic pathway, leading to the formation of Lys 48-linked polyubiquitin chain that targets Smo for proteasome-mediated degradation (Figure 10 ). Thus, multiple ubiquitination events provide a robust mechanism for Smo downregulation to prevent aberrant Smo activity in the absence of Hh.
Regulation of Smo trafficking and cell surface expression provides a new paradigm for how the ubiquitin pathway controls the activity of a membrane receptor. Unlike all the other cases whereby receptor ubiquitination is triggered by ligand or agonist stimulation and serves as a mechanism to control the duration of cell signaling, Smo ubiquitination occurs in the absence of ligand stimulation and serves as a mechanism to keep the basal pathway The mechanisms that regulate Smo trafficking and cell surface expression exhibit interesting similarities to as well as important differences from those regulating GPCRs. For example, it has been shown that agonist-induced downregulation of b2-Adrenergic Receptor (b2AR) is mediated by both b-arrestin and receptor ubiquitination [27] . In addition, b2AR internalization and degradation is regulated by both proteasome-and lysosomedependent mechanisms [27, 37] . However, b2AR ubiquitination is induced by agonist and serves as a mechanism for desensitization [27, 37] , whereas Smo ubiquitination is inhibited by Hh and serves as a mechanism for keeping pathway activity off in the absence of the ligand. b-arrestin binding to b2AR is induced by agonists and requires GRK2-mediated phosphorylation of the activated receptor [27] , whereas Krz binding to Smo is attenuated by Hh and Smo phosphorylation (Figure 7) . Although GPRK2/GRK2 also regulates Smo in Drosophila, its function appears to be uncoupled from that of Krz because loss of GPRK2 exhibits a phenotype distinct from that exhibited by loss of Krz [31, [38] [39] [40] . Furthermore, Krz can internalize Smo in the absence of GPRK2 [31] . b-arrestin is required for b2AR ubiquitination [27, 37] , whereas Krz inactivation does not significantly affect Smo ubiquitination (unpublished observations). Finally, while the proteasome inhibitor MG132 blocks agonist-induced b2AR internalization [27] , it does not prevent Smo internalization but instead inhibits Smo degradation after internalization (Figure 3) .
It is also interesting to note that b-arrestin has been implicated in the regulation of Smo trafficking and Shh signaling in vertebrates [29, 41, 42] . Furthermore, b-arrestin binds to mammalian Smo (mSmo) in a manner promoted by Shh and GRK2-mediated phosphorylation of mSmo C-tail [42, 43] , which is analogous to agonist-induced b-arrestin binding to GPCRs. However, instead of internalizing mSmo for degradation, barrestin appears to promote mSmo ciliary accumulation [42] , which correlates with its positive role in Shh signaling. Both Drosophila and vertebrate Smo proteins can activate trimeric Gproteins [44] [45] [46] , suggesting that they are not only structurally but also functionally related to GPCRs. It is conceivable that Smo proteins may employ multiple mechanisms utilized by GPCRs to control their intracellular trafficking and activity. Thus, it will be interesting to determine whether vertebrate Smo is also regulated by the ubiquitin pathway.
Materials and Methods
Mutations and Transgenes
Mutations used in this study are Uba1 H33 [19] , l(2)23Ad D28 /hrs [23] , krz 1 [47] , and UBPY KO [48] . Mutant clones were generated by FLP/FRT-mediated mitotic recombination as previously described [49] . The genotypes for making clones are as follows: Uba1 clones: yw 122; FRT42 Uba1 H33 /FRT42 hs-Myc-GFP; hrs clones: yw 122; l(2)23Ad D28 FRT40/ hs-Myc-GFP FRT40; krz or UBPY clones: yw 122; FRT82 krz 1 or UBPY KO /FRT82 hs-Myc-GFP. Transgenic RNAi lines used are UAS-Tsg101-RNAi (VDRC# 23944), UAS-Avl-RNAi (VDRC# 5413), and UAS-Rab5-RNAi (VDRC# 34096). UAS-Krz and UAS-UBPY are previously described [47, 48] [8, 13, 50] . CFP-tagged Fz2 is described [8] .
To construct Fz2/Smo chimeric proteins, the coding sequence for the wild type and mutant forms of SAID (aa 661-818) was amplified by PCR and inserted at a Kpn I site between the coding sequence for Fz2 and CFP. To construct Krz-YFP, the coding sequence of Krz was amplified by PCR and inserted between Not I/ Kpn I digestion sites of pUAST vector, and YFP was inserted in frame to the C-terminus of Krz between Kpn I/ XbaI digestion sites. Smo K6R , Smo K7R , and Smo K13R were generated using PCRbased site-directed mutagenesis to introduce K to R mutations in corresponding Lys residues.
Cell Culture, Transfection, Immunoprecipitation, Western Blot, and Immunostaining Drosophila S2 cells were cultured in Drosophila SFM (Invitrogen) with 10% fetal bovine serum, 100 U/ml of penicillin, and 100 mg/ml of streptomycin at 23uC. Transfection was carried out by Calcium Phosphate Transfection Kit (Specialty Media) according to the manufacturer's instructions. Hh-conditioned medium treatment was carried out as described [51] . Cells were treated with 50 mM MG132 (Calbiochem) for 4 h to inhibit proteasome or 20 mM NH 4 Cl (Sigma) for 18 h to inhibit lysosome. Immunoprecipitation and Western blot analysis were carried out using standard protocols as previously described [52] . For Smo cell surface staining assay, S2 cells were harvested and washed with PBS, fixed with 4% formaldehyde at room temperature for 20 min, and incubated with the mouse antiSmoN antibody in PBS at room temperature for 90 min. Cells were washed 3 times by PBS followed by secondary antibody staining. Immunostaining of imaginal discs was carried out as described [13, 49] . Quantification of immunostaining and autoradiography densitometric analysis was performed using ImageJ software. Antibodies used in this study were: mouse anti-SmoN (DSHB), rat anti-Ci 2A1 [53] , rabbit and mouse anti-Flag (Sigma), mouse anti-Myc (Santa Cruz), mouse anti-HA (Santa Cruz), mouse anti-GFP (Millipore), rabbit anti-GFP (Santa Cruz), rabbit anti-LacZ (ICN Pharmaceuticals, Inc.), anti-Ub (P4D1) (Santa Cruz), and anti-Poly-Ub K48 (Cell signaling).
Ubiquitination Assay
Ubiquitination assays were carried out based on the protocol described previously [21] . Briefly, Myc-Smo stably expressing S2 cells or S2 cells transfected with Smo variants with or without HAUb (wild type or mutants) were treated with MG132 or NH 4 Cl before harvesting. Cells were lysed in 100 ml of denaturing buffer (1% SDS/50 mM Tris, pH 7.5/0.5 mM EDTA/1 mM DTT). After incubation for 5 min at 100uC, the lysates were diluted 10-fold with lysis buffer and then subjected to immunoprecipitation and Western blot analysis.
RNAi in Drosophila S2 Cells dsRNA was generated by MEGAscript High Yield Transcription Kit (Ambion: #AM1334) according to the manufacturer's instruction. DNA templates targeting Uba1(aa 1-172), Krz(aa 191-365), UBPY(aa 25-191 and aa 124-290) or other DBUs (Table S1 ) were generated by PCR and used for generating dsRNA. Ptc RNAi was carried out as previously described [51] . dsRNA targeting the Fire Fly Luciferase coding sequence was used as a control. For RNAi knockdown experiments, S2 cells were cultured in serum free medium containing indicated dsRNA at 23uC for 8 h. After adding fetal bovine serum to a final concentration of 10%, dsRNA treated cells were cultured overnight before transfection. 48 h after transfection, cells were harvested for further analysis. Figure S1 Smo is accumulated on the cell surface in Uba1 mutant clones. Low (A, B) and high (A', B') magnification view of wing imaginal discs carrying Uba1 H33 mutant clones and immunostained with anti-SmoN (red) and anti-GFP (green) antibodies. Larvae were grown at 18uC after clone induction and shifted to 30uC for 24 (A, A') or 12 (B, B') h, followed by immunostaining with anti-SmoN antibody prior to membrane permeabilization. 
Supporting Information
